Vaccinations in patients with multiple sclerosis: A Delphi consensus statement
Agostino Riva(ASST Fatebenefratelli Sacco), Lucia Moiola(Vita-Salute San Raffaele University), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Massimo Galli(Luigi Sacco Hospital), Simone Vasilij Benatti(Ospedale San Paolo), Carla Tortorella(Carlo Forlanini Hospital), Massimo Origoni(Vita-Salute San Raffaele University), Cristina Scarpazza(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Ruggero Capra(Presidio Ospedaliero), Valeria Barcella, Luca Meroni(Luigi Sacco Hospital), Marco Capobianco(Ospedale San Luigi Gonzaga), Fabio Franzetti(Luigi Sacco Hospital), Luca Prosperini(Nini Hospital), Paola Cinque(University of California San Diego), Maria Michela Fasolo(ASST Fatebenefratelli Sacco), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Giancarlo Comi(University of Milan), Simonetta Gerevini(Ospedale Papa Giovanni XXIII)
Cited by 62
Related Papers
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
|Journal of Neuroinflammation|2016|896